Works about PIOGLITAZONE

Results: 979

NICE type 2 diabetes management guidance: What's new?

Published in:

Journal of Diabetes Nursing, 2022, v. 26, n. 2, p. 1

By:

Down, Su

Publication type:

Article

The therapeutic landscape of non-alcoholic steatohepatitis.

Published in:

Liver International, 2017, v. 37, n. 5, p. 634, doi. 10.1111/liv.13270

By:

Perazzo, Hugo;
Dufour, Jean ‐ François

Publication type:

Article

Medication assists diabetic symptoms from antipsychotics.

Published in:

Brown University Psychopharmacology Update, 2013, v. 24, n. 3, p. 6, doi. 10.1016/j.schres.2012.10.023

By:

Smith, R. C.;
Jin, H.;
Li, C.

Publication type:

Article

Pioglitazone promising for depression.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 8, p. 7
Publication type:: Article

Selective extraction and analysis of pioglitazone in cow plasma using a molecularly imprinted polymer combined with ESI ion mobility spectrometry.

Published in:

Journal of Separation Science, 2014, v. 37, n. 5, p. 573, doi. 10.1002/jssc.201301206

By:

Jafari, Mohammad Taghi;
Kamfirozi, Mohammad;
Jazan, Elham;
Ghoreishi, Seyed Mehdi

Publication type:

Article

E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model.

Published in:

Journal of Neuro-Oncology, 2012, v. 109, n. 2, p. 219, doi. 10.1007/s11060-012-0890-8

By:

Yoo, Jin;
Yang, Seung-Ho;
Lee, Jung;
Cho, Deog;
Kim, Hoon;
Kim, Sung;
Kim, Il;
Hong, Jae;
Sung, Jae;
Son, Byung;
Lee, Sang

Publication type:

Article

Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.

Published in:

Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00246-3

By:

Saini, Aryendu Kumar;
Saini, Rakesh;
Singh, Shubham

Publication type:

Article

Antiapoptotic and anti‐inflammatory effects of Pparγ agonist, pioglitazone, reversed Dox‐induced cardiotoxicity through mediating of miR‐130a downregulation in C57BL/6 mice.

Published in:

Journal of Biochemical & Molecular Toxicology, 2022, v. 36, n. 6, p. 1, doi. 10.1002/jbt.23041

By:

Pakravan, Golnaz;
Peymani, Maryam;
Abedpoor, Navid;
Safaeinejad, Zahra;
Yadegari, Mehrdad;
Derakhshan, Maryam;
Nasr Esfahani, Mohammad Hossein;
Ghaedi, Kamran

Publication type:

Article

Effects of antidiabetic drugs on bone metabolism.

Published in:

Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2024, v. 5, n. 1, p. 85, doi. 10.1515/almed-2024-0038

By:

Padilla Apuntate, Nuria;
Puerto Cabeza, Carmen G.;
Gallego Royo, Alba;
Goñi Ros, Nuria;
Abadía Molina, Claudia;
Acha Pérez, Javier;
Calmarza, Pilar

Publication type:

Article

Validation of an UPLC method for the determination of Pioglitazone Hydrochloride active substance in Pharmaceutical Dosage Forms.

Published in:

Journal of Research in Pharmacy, 2024, v. 28, n. 1, p. 385, doi. 10.29228/jrp.704

By:

BILGIC KARAAGAC, Sinem;
BILGIC ALKAYA, Dilek;
AYAZ SEYHAN, Serap;
OZTURK, Busra Nagihan

Publication type:

Article

Development and evaluation of taste masked orally disintegrating tablets of pioglitazone hydrochloride.

Published in:

Journal of Research in Pharmacy, 2022, v. 26, n. 6, p. 1619, doi. 10.29228/jrp.253

By:

THAKKER, Prashant;
SHAH, Jigna;
MEHTA, Tejal;
SHETTY, Vasant;
AWARE, Rahul;
KUCHEKAR, Ashwin

Publication type:

Article

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety.

Published in:

2018

By:

Jones, Jermaine D.;
Bisaga, Adam;
Metz, Verena E.;
Manubay, Jeanne M.;
Mogali, Shanthi;
Ciccocioppo, Roberto;
Madera, Gabriela;
Doernberg, Molly;
Comer, Sandra D.

Publication type:

journal article

Comparison of the Effect of Pioglitazone and Metformin on HOMA IR In Patient of Prediabetes.

Published in:

Indian Journal of Basic & Applied Medical Research, 2021, v. 10, n. 3, p. 43, doi. 10.36848/IJBAMR/2020/29215.55575

By:

Umar, Sayed Asif;
Bhosle, Deepak;
bhagat, Abhijeet

Publication type:

Article

Cure of Alzheimer's Dementia Requires Addressing All of the Affected Brain Cell Types.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 2049, doi. 10.3390/jcm12052049

By:

Fessel, Jeffrey

Publication type:

Article

Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006–2016.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3578, doi. 10.3390/jcm9113578

By:

Lin, Min-Hao;
Yang, Huang-Yu;
Yen, Chieh-Li;
Wu, Chao-Yi;
Jenq, Chang-Chyi;
Kuo, George;
Peng, Wei-Sheng;
Liu, Jia-Rou;
Tian, Ya-Chung;
Yang, Chih-Wei;
Anderson, Gerard F.;
See, Lai-Chu

Publication type:

Article

Resistance Training and Pioglitazone Lead to Improvements in Muscle Power During Voluntary Weight Loss in Older Adults.

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2013, v. 68, n. 7, p. 828, doi. 10.1093/gerona/gls258

By:

Marsh, Anthony P.;
Kyla Shea, M.;
Vance Locke, Rachel M.;
Miller, Michael E.;
Isom, Scott;
Miller, Gary D.;
Nicklas, Barbara J.;
Lyles, Mary F.;
Carr, Jeffery J.;
Kritchevsky, Stephen B.

Publication type:

Article

The Primary Care Diabetes Society's response to NICE on the draft type 2 diabetes guideline.

Published in:

Diabetes & Primary Care, 2015, v. 17, n. 2, p. 67

By:

Millar-Jones, David

Publication type:

Article

Evidence-based medicine. Part 5: Observational evidence.

Published in:

Diabetes & Primary Care, 2011, v. 13, n. 5, p. 284

By:

Holt, Tim

Publication type:

Article

Pioglitazone and bladder cancer: PCDS statement.

Published in:: Diabetes & Primary Care, 2011, v. 13, n. 4, p. 202
Publication type:: Article

Pioglitazone: Balancing risks and benefits.

Published in:

Diabetes & Primary Care, 2011, v. 13, n. 4, p. 199

By:

Kenny, Colin

Publication type:

Article

Determination of Rosiglitazone by Direct Analysis in Real-Time Mass Spectrometry.

Published in:

Analytical Letters, 2017, v. 50, n. 11, p. 1721, doi. 10.1080/00032719.2016.1248245

By:

Liu, Wenlong;
He, Yangfang;
Zhang, Hongmei;
Su, Rui;
Xiu, Yang;
Liu, Shuying

Publication type:

Article

Pioglitazone Eases Testicular Torsion/Detorsion-Induced Ischemia-Reperfusion Injury in Rats.

Published in:

Journal of Urological Surgery, 2023, v. 10, n. 2, p. 167, doi. 10.4274/jus.galenos.2022.2022.0047

By:

Şentürk, İrfan Yıldırım;
Değer, Müslim Doğan;
Aydın, Muhammed Ali;
Madendere, Serdar;
Kaya, Oktay;
Taştekin, Ebru;
Aktoz, Tevfik

Publication type:

Article

Identification of Potential Therapeutic Targets in the Liver of Pioglitazone-Treated Type 2 Diabetes Sprague-Dawley Rats via Expression Profile Chip and iTRAQ Assay.

Published in:

Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/8120847

By:

Lu, Zhong-Xia;
Xu, Wen-Jun;
Wu, Yang-Sheng;
Li, Chang-Yu;
Chen, Yi-Tao

Publication type:

Article

Paper supported long-term 3D liver co-culture model for the assessment of hepatotoxic drugs.

Published in:

Toxicology Research, 2018, v. 7, n. 1, p. 13, doi. 10.1039/c7tx00209b

By:

Wang, Yaqing;
Su, Wentao;
Wang, Li;
Jiang, Lei;
Liu, Yang;
Hui, Lijian;
Qin, Jianhua

Publication type:

Article

COMPARATIVE EFFECTS OF LOSARTAN AND PIOGLITAZONE ON INSULIN RESISTANCE IN RATS.

Published in:

Biomedica, 2014, v. 30, n. 3, p. 1

By:

SHAD, M. N.;
ZAHEER, Z.;
KAUSAR, S.;
CHIRAGH, S.

Publication type:

Article

Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical Studies.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 170, doi. 10.1002/cpdd.243

By:

Martin, Paul;
Gillen, Michael;
Millson, David;
Oliver, Stuart;
Brealey, Clive;
Surry, Dominic;
Sweeny, David;
Lau, David;
Leese, Philip

Publication type:

Article

Clinical implications of fracture severity risk with pioglitazone: a systematic review and meta-analysis of clinical randomized trials.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1357309

By:

Azhari, Hala F.;
Dawson, Jesse

Publication type:

Article

Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00545

By:

Li Sun;
Quan Yuan;
Tianhua Xu;
Li Yao;
Jiangmin Feng;
Jianfei Ma;
Lining Wang;
Changlong Lu;
Danan Wang

Publication type:

Article

Pioglitazone reduces serum ketone bodies in sodium‐glucose cotransporter‐2 inhibitor‐treated non‐obese type 2 diabetes: A single‐centre, randomized, crossover trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3137, doi. 10.1111/dom.15641

By:

Yang, Min;
Yue, Han;
Xu, Qinqin;
Shao, Shiying;
Chen, Yong

Publication type:

Article

Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3‐year prospective cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2969, doi. 10.1111/dom.15622

By:

Chang, Ming‐Ling;
Tai, Jennifer;
Cheng, Jur‐Shan;
Chen, Wei‐Ting;
Yang, Sien‐Sing;
Chiu, Cheng‐Hsun;
Chien, Rong‐Nan

Publication type:

Article

Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2606, doi. 10.1111/dom.15576

By:

Anson, Matthew;
Henney, Alex E.;
Zhao, Sizheng S.;
Ibarburu, Gema H.;
Lip, Gregory Y. H.;
Cuthbertson, Daniel J.;
Nabrdalik, Katarzyna;
Alam, Uazman

Publication type:

Article

A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2188, doi. 10.1111/dom.15526

By:

Lim, Soo;
Lee, Seung‐Hwan;
Min, Kyung‐Wan;
Lee, Chang Beom;
Kim, Sang Yong;
Yoo, Hye Jin;
Kim, Nan Hee;
Kim, Jae Hyeon;
Oh, Seungjoon;
Won, Jong Chul;
Kwon, Hyuk Sang;
Kim, Mi Kyung;
Park, Jung Hwan;
Jeong, In‐Kyung;
Kim, Sungrae

Publication type:

Article

In praise of pioglitazone: An economically efficacious therapy for type 2 diabetes and other manifestations of the metabolic syndrome.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3093, doi. 10.1111/dom.15222

By:

Bell, David S. H.;
Jerkins, Terri

Publication type:

Article

Validation of a diet‐induced Macaca fascicularis model of non‐alcoholic steatohepatitis with dietary and pioglitazone interventions.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1068, doi. 10.1111/dom.14955

By:

Camacho, Raul C.;
Polidori, David;
Chen, Tao;
Chen, Bin;
Hsu, Helen Han;
Gao, Bin;
Marella, Mathieu;
Lubomirski, Mariusz;
Beavers, Traymon;
Cabrera, Javier;
Wong, Peggy;
Nawrocki, Andrea R.

Publication type:

Article

Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1112, doi. 10.1111/dom.14936

By:

Bril, Fernando;
Kalavalapalli, Srilaxmi;
Lomonaco, Romina;
Cusi, Kenneth

Publication type:

Article

Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 426, doi. 10.1111/dom.14885

By:

Moody, Alexander J.;
Molina‐Wilkins, Marjorie;
Clarke, Geoffrey D.;
Merovci, Aurora;
Solis‐Herrera, Carolina;
Cersosimo, Eugenio;
Chilton, Robert J.;
Iozzo, Patricia;
Gastaldelli, Amalia;
Abdul‐Ghani, Muhammad;
DeFronzo, Ralph A.

Publication type:

Article

Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1150, doi. 10.1111/dom.14687

By:

Spence, J. David;
Viscoli, Catherine;
Kernan, Walter N.;
Young, Lawrence H.;
Furie, Karen;
DeFronzo, Ralph;
Abdul‐Ghani, Muhammad;
Dandona, Paresh;
Inzucchi, Silvio E.

Publication type:

Article

Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steatohepatitis: A hierarchical network meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 980, doi. 10.1111/dom.14304

By:

Panunzi, Simona;
Maltese, Sabina;
Verrastro, Ornella;
Labbate, Luca;
De Gaetano, Andrea;
Pompili, Maurizio;
Capristo, Esmeralda;
Bornstein, Stefan R.;
Mingrone, Geltrude

Publication type:

Article

Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2096, doi. 10.1111/dom.13774

By:

Garry, Elizabeth M.;
Buse, John B.;
Gokhale, Mugdha;
Lund, Jennifer L.;
Nielsen, Matthew E.;
Pate, Virginia;
Stürmer, Til

Publication type:

Article

Effect of switching from pioglitazone to the sodium glucose co‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus: An open‐label, prospective, randomized, parallel‐group comparison trial

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 710, doi. 10.1111/dom.13557

By:

Cho, Kyu Yong;
Nakamura, Akinobu;
Omori, Kazuno;
Takase, Takahiro;
Miya, Aika;
Manda, Naoki;
Kurihara, Yoshio;
Aoki, Shin;
Atsumi, Tatsuya;
Miyoshi, Hideaki

Publication type:

Article

Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin‐treated T2DM patients: Results from the Qatar Study.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 705, doi. 10.1111/dom.13546

By:

Abdul‐Ghani, Muhammad;
Migahid, Osama;
Megahed, Ayman;
Singh, Rajvir;
Fawaz, Mohammad;
DeFronzo, Ralph A.;
Jayyousi, Amin

Publication type:

Article

Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti‐diabetic therapies.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 210, doi. 10.1111/dom.13512

By:

Bell, David S. H.;
Goncalves, Edison

Publication type:

Article

Impact of treatment with pioglitazone on stroke outcomes: A real‐world database analysis.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2140, doi. 10.1111/dom.13344

By:

Morgan, Christopher Ll;
Inzucchi, Silvio E.;
Puelles, Jorge;
Jenkins‐Jones, Sara;
Currie, Craig J.

Publication type:

Article

Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 1075, doi. 10.1111/dom.13189

By:

Migahid, Osama;
Megahed, Ayman;
Kamal, Dalia;
Jayyousi, Amin;
Abdul‐Ghani, Muhammad;
DeFronzo, Ralph A.;
Singh, Rajvir

Publication type:

Article

Practical strategies for improving outcomes in T2DM: The potential role of pioglitazone and DPP4 inhibitors.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 786, doi. 10.1111/dom.13169

By:

Del Prato, Stefano;
Chilton, Robert

Publication type:

Article

Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 129, doi. 10.1111/dom.13049

By:

Garry, Elizabeth M.;
Buse, John B.;
Lund, Jennifer L.;
Pate, Virginia;
Stürmer, Til

Publication type:

Article

Corrigendum.

Published in:: Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 912, doi. 10.1111/dom.12965
Publication type:: Article

News and Views.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 5, p. 542, doi. 10.1111/dom.12659

By:

Idris, Iskandar

Publication type:

Article

Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 266, doi. 10.1111/dom.12608

By:

Erdmann, E.;
Harding, S.;
Lam, H.;
Perez, A.

Publication type:

Article

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1198, doi. 10.1111/dom.12555

By:

Kaku, K.;
Katou, M.;
Igeta, M.;
Ohira, T.;
Sano, H.

Publication type:

Article